Tositumomab is a mouse monoclonal antibody that targets CD20 antigen. Tositumomab could combine with iodine-131 to produce a radiopharmaceutical for the treatment of refractory, advanced non-Hodgkin lymphoma.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.